Market Overview: The global market for intranasal drug and vaccine delivery reached a value of USD 9.1 Billion in 2022 and is projected to attain USD 19.6 Billion by 2032. It is expected to exhibit a robust compound annual growth rate (CAGR) of 8.9% throughout the forecast period. Key drivers of this market expansion include the increasing incidence of chronic diseases like diabetes, asthma,...